Saturday 17 October 2026
Export AZTA’s income statement to Excel — free account
Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
34.09
2.43
−6.65%
Follow AZTA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 6 | 5 | 5 |
| (3.19%) | (3.51%) | (10.65%) | (7.72%) | ||
| (2.68%) | (2.93%) | (8.79%) | (6.31%) | ||
ROIC |
(1.21%) | (1.22%) | (9.23%) | (9.27%) | |
Return on Tangible Assets |
(8.93%) | (9.06%) | (27.02%) | (21.15%) | |
Average Days of Receivables |
93.37 | 92.11 | 84.54 | 88.91 | |
Free Cash Flow per Share |
0.84 | 0.67 | 0.65 | 0.22 | |
Free Cash Flow |
38.32 | 30.93 | 30.05 | 9.88 | |
Capital Expenditures |
(33.86) | (32.30) | (32.29) | (28.09) | |
| Other line items | |||||
Cash ROIC |
1.85% | 1.45% | 1.55% | 0.54% | |
Accounts Receivable Turnover |
3.60 | 3.90 | 4.15 | 4.48 | |
Accounts Payable Turnover |
9.11 | 9.36 | 9.19 | 8.88 | |
Inventory Turnover |
4.42 | 4.04 | 4.10 | 4.30 | |
Average Days of Payables |
42.56 | 42.90 | 36.42 | 41.85 | |
Days of Inventory on Hand |
84.56 | 91.24 | 86.30 | 84.05 | |
Tax Rate |
(4.42) | (5.39) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
5.12% | 5.46% | 5.75% | 5.82% | |
Selling, General and Administrative Expense of Revenue |
44.05% | 42.38% | 41.96% | 41.93% | |
Share Based Compensation of Revenue |
3.52% | 3.33% | 2.99% | 3.16% | |
Operating CF/Net income |
(1.29) | (1.05) | (0.36) | (0.31) | |
Depreciation/Fixed assets |
0.39 | 0.36 | 1.19 | 1.18 | |
Capex/Depreciation |
(0.57) | (0.58) | (0.16) | (0.14) | |
Revenue per Share |
12.98 | 12.96 | 12.95 | 13.55 | |
Operating CF per Share |
1.58 | 1.38 | 1.35 | 0.84 | |
Capex per Share |
(0.74) | (0.70) | (0.70) | (0.62) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 |
Columns are period end dates